The Biotech Startups Podcast
By Excedr
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Excedr
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 149
Description
The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.
| Episode | Date |
|---|---|
|
🧬 NASA, Harvard & Biotech: A Journey to Investing at Menlo Ventures | Johnny Hu (Part 1/4)
|
May 26, 2025 |
|
🧬 Simulating Life & Accelerating Discovery: Deep Origin’s Biotech Vision | Michael Antonov (Part 4/4)
|
May 22, 2025 |
|
🧬 Debugging Aging: How a VR Pioneer is Revolutionizing Longevity | Michael Antonov (Part 3/4)
|
May 19, 2025 |
|
🧬 Building Oculus: Innovation, Grit & the $2 Billion VR Revolution | Michael Antonov (Part 2/4)
|
May 15, 2025 |
|
🧬 The Borrowed Computer That Built Oculus - An Unlikely Biotech Journey | Michael Antonov (Part 1/4)
|
May 12, 2025 |
|
🧬 The Secret to Biotech Success: Time, Tools & Teamwork | Bogdan Knezevic (Part 4/4)
|
May 08, 2025 |
|
🧬 Purpose-Driven Innovation: Building Teams to Solve Biotech Problems | Bogdan Knezevic (Part 3/4)
|
May 05, 2025 |
|
🧬 Letting Go to Level Up: Oxford, Identity, & Tenacity in Biotech | Bogdan Knezevic (Part 2/4)
|
May 01, 2025 |
|
🧬Immigrant Grit & Athletic Discipline: Building a Biotech Legacy | Bogdan Knezevic (Part 1/4)
|
Apr 28, 2025 |
|
🧬 Redefining Biotech: Building Enduring Value Beyond Acquisition | Rabia Khan (Part 4/4)
|
Apr 24, 2025 |
|
🧬 Sales Skills & Resilience: Hidden Drivers of Biotech Success | Rabia Khan (Part 3/4)
|
Apr 21, 2025 |
|
🧬 Rabia Khan - Serna Bio: Bridging Science & Tech—PhDs, MBAs, & Biotech Innovation (Part 2/4)
|
Apr 17, 2025 |
|
🧬 Rabia Khan - Serna Bio: Unraveling the Genetics of AI-Driven Drug Discovery (Part 1/4)
|
Apr 14, 2025 |
|
🧬Alfredo Andere - LatchBio: Revolutionizing Biopharma Data & Mastering Enterprise Sales (Part 4/4)
|
Apr 10, 2025 |
|
🧬Alfredo Andere - LatchBio: Building Biotech Data Tools to Revolutionize Life Sciences (Part 3/4)
|
Apr 07, 2025 |
|
🧬Alfredo Andere - LatchBio: College Friends, Biotech Beginnings & Thoughtful Persistence (Part 2/4)
|
Apr 03, 2025 |
|
🧬 Alfredo Andere - LatchBio: Conquering Berkeley's EECS & Building a Global Vision (Part 1)
|
Mar 31, 2025 |
|
🧬 Michael Paliotti - MilliporeSigma: Master Biotech Sales & Build High-Performance Teams (Part 4/4)
|
Mar 27, 2025 |
|
🧬 Michael Paliotti: Blending Science, Sales, and Side Hustles in Biotech (Part 3/4)
|
Mar 24, 2025 |
|
🧬 Michael Paliotti: Navigating Biotech Careers & Building Lasting Relationships (Part 2/4)
|
Mar 20, 2025 |
|
🧬 Michael Paliotti: Navigating a Winding Path to Biotech Success (Part 1/4)
|
Mar 17, 2025 |
|
🧬 Stavros Papadopoulos: Transforming Data Management (Part 4/4)
|
Mar 13, 2025 |
|
🧬 Stavros Papadopoulos: Scaling TileDB & Revolutionizing Data Infrastructure (Part 3/4)
|
Mar 10, 2025 |
|
🧬Stavros Papadopoulos: How Serendipity Sparked TileDB's Startup Journey (Part 2/4)
|
Mar 06, 2025 |
|
🧬 Stavros Papadopoulos: A Journey in Computer Science & Data Management (Part 1/4)
|
Mar 03, 2025 |
|
🧬 Becky Beattie: Scaling LaunchBio & Democratizing Biotech Entrepreneurship (Part 2/2)
|
Feb 27, 2025 |
|
🧬 Becky Beattie: From Rural Beginnings to Building a National Biotech Network (Part 1)
|
Feb 24, 2025 |
|
🧬 Dr. Kate Yen: Scaling a Biotech, Running Lean, & Utilizing Translational Biology (Part 2)
|
Feb 20, 2025 |
|
🧬 Kate Yen - Part 1 | From Academia to Biotech Leader | Translating Research into Cancer Therapies | Early Days at Merck & Agios
|
Feb 17, 2025 |
|
🧬 Oguzhan Atay - Part 2 | From Immigrant to Biotech Innovator | Battling Deportation with Nobel Laureate Support | Building a $140M Prenatal Testing Empire
|
Feb 13, 2025 |
|
🧬 Oguzhan Atay - Part 1 | From Small-Town Turkey to Stanford PhD | Solving Cell Cycle Mysteries | Building a Biotech During a Global Pandemic
|
Feb 10, 2025 |
|
🧬 Parag Shah - Part 2 | Scaling a Multi-Billion Dollar Life Sciences Fund | Culture, Capital & Entrepreneurship | The K2 HealthVentures Story
|
Feb 06, 2025 |
|
🧬 Parag Shah - Part 1 | Rethinking Biotech Startup Funding | Building Smarter Capital Strategies | Risk, Reward & Leadership in Investing
|
Feb 03, 2025 |
|
🧬 Jason C. Foster - Part 2 | Manufacturing Brighter Futures | From Richmond to London: Building a Biotech Empire | Culture Eats Strategy for Breakfast
|
Jan 30, 2025 |
|
🧬 Jason C. Foster - Part 1 | From Paper Routes to Pharma | Navigating the Dot-Com Bubble | Building a $1B Addiction Medicine Business in 4 Years
|
Jan 27, 2025 |
|
🧬 Rafael Rosengarten - Part 4 | Lessons in Scaling a Biotech Startup | Using AI to Transform Cancer Diagnostics | The Genialis Supermodel & krasID
|
Jan 23, 2025 |
|
🧬 Rafael Rosengarten - Part 3 | Leveraging AI in Precision Medicine | How Predictive Biomarkers Transform Oncology | Lessons from Scaling a Startup
|
Jan 20, 2025 |
|
🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship
|
Jan 16, 2025 |
|
🧬 Rafael Rosengarten - Part 1 | From Salt Marsh to Biotech CEO | Snorkeling into Science | Choosing Marine Biology Over Cooking on a Mediterranean Yacht
|
Jan 13, 2025 |
|
🧬 Cyriac Roeding - Part 4 | Revolutionizing Cancer Detection & Therapy | Harnessing Synthetic Biology to Reshape Diagnostics | Solving Biotech’s Toughest Problems
|
Jan 09, 2025 |
|
🧬Cyriac Roeding - Part 3 | Founding Shopkick During the 2008 Financial Crisis | Transforming Retail with Mobile Tech | Exploring AI’s Use in Clinical Trials & Reshaping Drug Development
|
Jan 06, 2025 |
|
🧬 Cyriac Roeding - Part 2 | From Digital Clocks to Global Mobile Marketing | Cracking Coca-Cola's 160 Million Bottle Code | Silicon Valley's Pine-Scented Entrepreneurship | Leapfrogging Technology in the Amazon Jungle
|
Jan 02, 2025 |
|
🧬 Cyriac Roeding - Part 1 | From Flea Market Entrepreneur to Silicon Valley CEO | Reinvention During an Exchange Year | Finding Perspective in Japanese Business Culture
|
Dec 30, 2024 |
|
🧬 Kate Neville - Part 4 | Balancing IP Enforcement & Licensing | Leveraging Shelved Pharma Assets | Building Resilient IP Portfolios
|
Dec 19, 2024 |
|
🧬Kate Neville - Part 3 | Fundamentals of IP Strategy for Biotechs | Safeguarding Discoveries & Technology | Aligning Science with Patents | Navigating Global Patent Considerations
|
Dec 16, 2024 |
|
🧬Kate Neville - Part 2 | Navigating Law School as a Scientist | From Patent Agent to Lawyer | Thriving at the Intersection of Science & Law | Continuous Learning in Diverse Scientific Fields
|
Dec 12, 2024 |
|
🧬 Kate Neville - Part 1 | From Youngest of Six to Patent Law Pioneer | When Chemistry Sets Spark Scientific Careers | Leading Through Autonomy | Serendipitous Path from Lab Bench to IP Law
|
Dec 09, 2024 |
|
🧬 Barry Ticho - Part 4 | Founding Verve Therapeutics Over Breakfast | Gene Editing for Cardiovascular Disease | Leadership Lessons From a First-Time Founder | Stoke’s Vision for RNA-Based Medicines
|
Dec 05, 2024 |
|
🧬 Barry Ticho - Part 3 | Lessons From Rigorous Drug Development | Industry vs. Academic Research Standards | A Patient-Centered Approach to Clinical Trials | How RNA is Shaping Modern Medicine
|
Dec 02, 2024 |
|
🧬Barry Ticho - Part 2 | Zebrafish Hearts & Pediatric Cardiology | Balancing Lab Work & Clinical Practice | Navigating Academic Medicine's Challenges | The Draw of Biopharma & Translational Medicine
|
Nov 28, 2024 |
|
🧬Barry Ticho - Stoke Therapeutics - Part 1 | From Family of Physicians to Vision-Driven Scientist | Barry’s MD-PhD Journey | Leadership Through Critical Thinking & Resilience | The Journey From Academia to Industry
|
Nov 25, 2024 |
|
🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio
|
Nov 21, 2024 |
|
🧬Chris Moxham - Transcripta Bio - Part 3 | Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development
|
Nov 18, 2024 |
|
🧬Chris Moxham - Transcripta Bio - Part 2 | From Eli Lilly Recruit to NYC Lab Builder | Leading High-Stakes Drug Discovery | Pioneering Quantitative Biology | "Making the Trains Run on Time"
|
Nov 14, 2024 |
|
🧬Chris Moxham - Transcripta Bio - Part 1 | From Long Island to Biotech Pioneer | Cornell's Pivotal Role in Research Passion | Strategic Leap to Pharma Industry | Cultivating Effective Leadership in Science
|
Nov 11, 2024 |
|
🧬Michael Chen - Nuclera - Part 2 | From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating a Biotech GTM Strategy
|
Nov 07, 2024 |
|
🧬Michael Chen - Nuclera - Part 1 | Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There
|
Nov 04, 2024 |
|
🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics
|
Oct 31, 2024 |
|
🧬 Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen
|
Oct 28, 2024 |
|
🧬Neela Patel - Bonum Therapeutics - Part 2 | Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition
|
Oct 24, 2024 |
|
🧬 Neela Patel - Bonum Therapeutics - Part 1 | Growing Up in an Intellectual Household | How One Biology Class Inspired Her | Working With Influential Scientists at DNAX | Pursuing the Intersection of Science & Business
|
Oct 21, 2024 |
|
🧬eMalick Njie, Ph.D - Ecotone - Part 4 | Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs
|
Oct 17, 2024 |
|
🧬 eMalick Njie, Ph.D - Ecotone - Part 3 | Founding an AI-Powered Biotech | Overcoming Challenges & Personal Sacrifices | Importance of Team Alignment | Combining AI, Genetics, & Population Studies
|
Oct 14, 2024 |
|
🧬eMalick Njie, Ph.D - Ecotone - Part 2 | What is Memory? | Playing “Stump the Professor” | Lab Coat Labs vs Sandals Labs | Wanting to Help People at Scale
|
Oct 10, 2024 |
|
🧬eMalick Njie, Ph.D - Ecotone - Part 1 | Growing Up in the Gambia | The Unending Book of Neuroscience | Being a Professional Scientist | How to Lose Your MIT Recommendation Letter: 101
|
Oct 07, 2024 |
|
🧬Barbara Alcaraz Silva - J.P. Morgan - Part 4 | Barbara’s Pivot into Banking | The Power of Mentorship & Resilience | Seizing Unexpected Opportunities | The Challenges of Building a Career in Science & Finance
|
Oct 03, 2024 |
|
🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 3 | From Academia to Entrepreneurship, Investing, & Advising | Co-Founding a Startup | Challenges of Early-Stage Company Building | Improve Your Investor Pitch & Connect with the Right People
|
Sep 30, 2024 |
|
🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 2 | Mentorship & Research at the Beckman Laser Institute | An Entrepreneurial PhD Experience | Exploring Stem Cell Biology in London | Navigating Networking & Postdoc Opportunities
|
Sep 26, 2024 |
|
🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 1 | Living the American Dream & Emigrating From Mexico | Soaking Up Experiences & Embracing Opportunities | Researching at the Harvard of Mexico | Presenting In Spanish at a National Conference
|
Sep 23, 2024 |
|
🧬 Derek Hennecke - Kincell Bio - Part 4 | Building & Scaling Xcelience | Buy-Side vs. Sell-Side of M&A | The Importance of Continuous Learning | Transition into Investing & Board Member Work
|
Sep 19, 2024 |
|
🧬 Derek Hennecke - Kincell Bio - Part 3 | Starting an Operations Role in Egypt | The Importance of Teamwork | Moving into Biologics & Overseeing GMP Operations | Buying a Business & Founding Xcelience
|
Sep 16, 2024 |
|
🧬 Derek Hennecke - Kincell Bio - Part 2 | Taking Risks and Jumping for the Right Opportunity | The Willingness To Do, Opens Doors | Your Job is More than the Products It is Producing | Building Trust in Other Countries
|
Sep 12, 2024 |
|
🧬 Derek Hennecke - Kincell Bio - Part 1 | Sales Means Having Two Ears and One Mouth | The Support of a Partner Can Make or Break a Career | Skip the MBA
|
Sep 09, 2024 |
|
🧬 Doug Drysdale - Cybin - Part 4 | The Challenges of Running a Public Company | Transforming Psychiatric Treatments Through Psychedelic Compounds | Developing Breakthrough Therapies in Depression & Anxiety
|
Sep 05, 2024 |
|
🧬 Doug Drysdale - Cybin - Part 3 | Jumping from BD to M&A | Leveraging Debt for Strategic Acquisitions | The Importance of Cultural Fit in Successful Deals | Making an Impact at Norwich, Alvogen, & Pernix Therapeutics
|
Sep 02, 2024 |
|
🧬 Doug Drysdale - Cybin - Part 2 | Deals Only Get Done in Person | Learning Financing Through a Company’s Hardship | Bureaucracy in the Workplace | How to Educate Yourself to Determine Good Licensing Deals
|
Aug 29, 2024 |
|
🧬 Doug Drysdale - Cybin - Part 1 | One Teacher Can Change Your Whole Perspective | The Forefront of the Human Genome Project | How Loss Taught Him Not to Take Life For Granted | Learning How to Be Personable in Sales
|
Aug 26, 2024 |
|
🧬 Noam Solomon - Immunai - Part 4 | How Searching for Investors is Like Finding a Life Partner | Luck In Fundraising | The Optimal Features of the Immune System | The Advice to Take More Risks
|
Aug 22, 2024 |
|
🧬 Noam Solomon - Immunai - Part 3 | Deciphering the Book That is the Human Immune System | Building Immunai’s Team | The Importance of Single Cell Multi-Omics | Big Pharma & Dancing With Gorillas
|
Aug 19, 2024 |
|
🧬 Noam Solomon - Immunai - Part 2 | The Value of Attending Prestigious Institutions | Immunai’s Genesis | AI, Machine Learning, & Their Applications in the Life Sciences | Mapping the Human Immune System
|
Aug 15, 2024 |
|
🧬 Noam Solomon - Immunai - Part 1 | Attending Undergrad at 14 Year Old | How Mathematics Can Make You a Lone Wolf | The Difference Between Noam’s Two PhDs | The Resilience Required for Entrepreneurship
|
Aug 12, 2024 |
|
🧬 Shekhar Mitra - InnoPreneur & P&G - Part 4 | Finding Foundational Intrapreneurship at P&G | Early Innovation in Drug Discovery & Development | Community & Diversity Leadership in Arts & STEM
|
Aug 08, 2024 |
|
🧬 Shekhar Mitra - InnoPreneur & P&G - Part 3 | The First Big Innovation Center in Asia | The Whole Work of Leadership | Noticeability Driven Through Technology | Developing Emotional Drivers
|
Aug 05, 2024 |
|
🧬 Shekhar Mitra - InnoPreneur & P&G - Part 2 | Columbia & Yale: Collaborating with Top Physicists | Moving from Academia to Procter & Gamble | Navigating Challenges, Celebrating Successes | Leading Clinical Trials & Working with the FDA
|
Aug 01, 2024 |
|
🧬 Shekhar Mitra - InnoPreneur & P&G - Part 1 | Growing Up in a Multigenerational Household | Undergraduate Experience at IIT | Groundbreaking Lab Research at Columbia | Diverse Experiences in New York City
|
Jul 29, 2024 |
|
🧬 Nathan Clark - Ganymede - Part 4 | Data Integration & Automation in the Life Sciences | Building a Technical Team & Go-To-Market Motion | Creating Efficient Data Infrastructures | Automating Complex Workflows
|
Jul 25, 2024 |
|
🧬 Nathan Clark - Ganymede - Part 3 | Parallels Between Benchling & Salesforce | Getting Customers to Fully Buy-In | Managing the “Writhing Snake of Data” | Ganymede Achieves Escape Velocity Growth
|
Jul 22, 2024 |
|
🧬 Nathan Clark - Ganymede - Part 2 | Moving from Goldman Sachs to Fintech | Exploring Product Management at Affirm | Leveraging Data & Building Tech Solutions| Impacting Scientific Progress at Benchling
|
Jul 18, 2024 |
|
🧬 Nathan Clark - Ganymede - Part 1 | Early Influence of Entrepreneurs | Developing Passions for Both Finance & Life Sciences | Fundamentals of Trading & Finances | Experiences & Opportunities at Goldman Sachs
|
Jul 15, 2024 |
|
🧬 David Li - Meliora Therapeutics - Part 4 | Mechanism Identification in Biotech | AI & ML in Drug Development | Creating a New Method for Drug Discovery | Fundraising for Meliora | Building a Foundational Startup Team
|
Jul 11, 2024 |
|
🧬 David Li - Meliora Therapeutics - Part 3 | Developing a Blood-Based Lung Cancer Test | The Rifle-Shot Nature of Biotech | Software Vs. Biotech Product Market Fit | The Super Power all Startups Need
|
Jul 08, 2024 |
|
🧬 David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups
|
Jul 03, 2024 |
|
🧬 David Li - Meliora Therapeutics - Part 1 | Childhood in China and Kentucky | Early Opportunities in Research & Biology | Benefits of Dual Degrees | Experiences & Opportunities while Investment Banking at Goldman Sachs
|
Jul 01, 2024 |
|
🧬 Mark Kotter - bit.bio - Part 4 | Democratizing Access to Cells & the Evolution of bit.bio | A Financial Journey from Angel Investment to IPO | Building a Tech Bio Platform & Mark’s 10-Year Vision
|
Jun 27, 2024 |
|
🧬 Mark Kotter - bit.bio - Part 3 | Success in Academia vs. Industry | Vital Things All Founders Should Know | The Importance of Company Culture | bit.bio & the Operating System of Life
|
Jun 24, 2024 |
|
🧬 Mark Kotter - bit.bio - Part 2 | Navigating Between the Clinical & Research Worlds | Lessons in Combining Different Fields | The Evolution of Cell Therapies | Transitioning from Academia to Entrepreneurship
|
Jun 20, 2024 |
|
🧬 Mark Kotter - bit.bio - Part 1 | Childhood Experiences in Different Countries | Overcoming Dyslexia & Developing Math Skills | Pivoting His Career to Science and Medicine | Facilitating Curiosity Via Research & Lab Experiences
|
Jun 17, 2024 |
|
🧬 Quin Wills - Ochre Bio - Part 4 | Quin’s Journey Through Y Combinator | The Role of Empathy in Team Dynamics | Adapting in a Shifting Biotech Industry | Ochre Bio’s Fundraising Journey & Future Plans
|
Jun 13, 2024 |
|
🧬 Quin Wills - Ochre Bio - Part 3 | University of Oxford’s Single Cell Consortium | The Pitfalls of Californian Entrepreneurships | Dinner Table Origins of Ochre Bio | The Laws that Guide Ochre Bio
|
Jun 10, 2024 |
|
🧬 Quin Wills - Ochre Bio - Part 2 | Pursuing Dual Masters at Oxford & Cambridge | Moving from Genomics to RNA Research | Balancing Academia & Entrepreneurship | The Challenges of Product-Market Fit in Biotech
|
Jun 06, 2024 |
|
🧬 Quin Wills - Ochre Bio - Part 1 | Childhood Moments in Johannesburg | A Passion for Science Grows with an Evolving Society | Academic Experience in Biology and Genetics | Exposure to Bioinformatics and Big Data
|
Jun 03, 2024 |
|
🧬 Grant Aarons - FabricNano - Part 3 | Meeting His Co-Founder at Entrepreneur First | Importance of Sales to the Scientific Community | Disrupting the Petrochemical Industry | The Dark Horse of Biology, Synthetic Biology
|
May 29, 2024 |
|
🧬 Grant Aarons - FabricNano - Part 2 | The Defensibility of Software Companies | Studying Econometrics at London Business School | Joining Entrepreneur First | Becoming a Biotech Startup CEO & Navigating the Startup Journey
|
May 22, 2024 |
|
🧬 Grant Aarons - FabricNano - Part 1 | How NYC Shaped a Love of Engineering | Benefitting from Great Diversity at Cooper Union | Experiences & Opportunities at the Federal Reserve Bank of New York | Impact of the Economy on Deep Tech
|
May 15, 2024 |
|
🧬 Bryan Dechairo - Sherlock Biosciences - Part 3 | Assurex’s Journey From Garage to GeneSight | Keeping a Team Together Through the M&A Process | Building a Diagnostics Company During Covid | What Sherlock & Netflix Have in Common
|
May 08, 2024 |
|
🧬 Bryan Dechairo - Sherlock Biosciences - Part 2 | Transitioning From a Small Startup to Pfizer | Big Data's Role in Modern Genetics | Building & Leading Dynamic Teams | The Evolution of Personalized Medicine
|
May 01, 2024 |
|
🧬 Bryan Dechairo - Sherlock Biosciences - Part 1 | A Love of Science Blossoming from a 10-Acre Hobby Farm | Experiencing Great Diversity at UC Berkeley | Growth & Enjoyment of Startups | Unexpected Travels to Pursue a Dream Overseas
|
Apr 24, 2024 |
|
🧬 Terry Lo - Vizgen - Part 3 | Transitioning to Vizgen From Akoya | What is Spatial Genomics | The Importance of Genetic Mapping | How to Grow Your Company During Turbulent Times
|
Apr 17, 2024 |
|
🧬 Terry Lo - Vizgen - Part 2 | Terry’s Move from Big Pharma to Diagnostics | Introduction to Spatial Biology | Navigating Regulatory & Reimbursement Challenges in Diagnostics | Balancing Multiple Roles in M&A Negotiations
|
Apr 10, 2024 |
|
🧬 Terry Lo - Vizgen - Part 1 | Leveraging Passion for Science to Succeed in Finance | Sales Excellence as an Introvert Through Competition | Financial Modeling & Creating Proper Deal Structure | How Not To Be A Jack of All Trades
|
Apr 03, 2024 |
|
🧬 Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy | The Critical Importance of Alignment
|
Mar 27, 2024 |
|
🧬 Mike Stadnisky - Thielsen Capital - Part 2 | Transitioning from Academia to Business | Breaking Into Business Development | Finding Decision Makers & Champions | Navigating Partnerships & Strategy
|
Mar 20, 2024 |
|
🧬 Mike Stadnisky - Thielsen Capital - Part 1 | Familial Exposure to Business & Science at a Young Age | The Importance of “Care Before You Share” | Actively Managing Your Time | A PhD is a 10,000 Hour Degree
|
Mar 13, 2024 |
|
🧬 Martin Brenner - iBio - Part 3 | Transitioning from Big Pharma to Biotech Startups | Lessons in Flexibility, Resilience, & Adaptability | Challenging Long-Held Beliefs in Drug Discovery | The Evolution & Future of iBio
|
Mar 06, 2024 |
|
🧬 Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an Exit From Big Pharma
|
Feb 28, 2024 |
|
🧬 Martin Brenner - iBio - Part 1 | How Childhood Influences Shape Career Paths | Unexpected Crossovers Between Engineering & Veterinary Clinics | Eli Lilly Nurturing His Professional Development | Communication Can Make or Break Leadership
|
Feb 21, 2024 |
|
🧬 Jeff Kim - Slingshot Biosciences - Part 3 | Bucking the Status Quo | Raising Capital During Peak COVID | How To Find & Retain Great Talent | Building Partnerships with Distributors
|
Feb 14, 2024 |
|
🧬 Jeff Kim - Slingshot Biosciences - Part 2 | Working Toward One Goal In Industry | How Great Loss Prompted Professional Growth | Transitioning From a Basement Lab to a Thriving Company | A 6-Month Startup Idea Exceeding 12 Years of Operation
|
Feb 07, 2024 |
|
🧬 Jeff Kim - Slingshot Biosciences - Part 1 | Parental Freedom, Curiosity, & Self-Teaching | Music Accentuating a Passion for Science | The Benefits of Graduate Responsibilities as an Undergrad | Finding Fit & Balancing Research & the Arts
|
Jan 31, 2024 |
|
🧬 Stephanie Sirota - RTW Investments - Part 3 | The Emergence of Crossover Rounds | Building & Explaining Your Investment Thesis | Creating a .600 Batting Average Investment Fund | Transparency Between Investor & Founder | How to Get LPs to Say “Yes”
|
Jan 24, 2024 |
|
🧬 Stephanie Sirota - RTW Investments - Part 2 | Understanding Investment Banking’s Role in the Biosciences | Finding the Benefits of Your Uniqueness | Unexpected Pivots & Finding Passion in Your Work | Advice on Dealing with Bear Markets
|
Jan 17, 2024 |
|
🧬 Stephanie Sirota - RTW Investments - Part 1 | Early Influences on Leadership Style | Competitive Tennis Fosters Professional Drive | The Inverse Importance of Coaching | The Ending of a Dream to Open New Doors | Organically Choosing Your Track
|
Jan 10, 2024 |
|
🧬 Kittu Kolluri - Neotribe Ventures - Part 3 | Influence vs Control as a VC | Being a Leader in Venture vs a Leader in a Company | Starting Neotribe as a Passionate Rage Against the Status Quo | Sunk Cost vs Opportunity Cost | Optimizing Customer Acquisit
|
Jan 03, 2024 |
|
🧬 Kittu Kolluri - Neotribe Ventures - Part 2 | The Importance of Co-Authoring a Culture Statement | The Difference Between Leadership & Management | Raising Funds in Down-Market Conditions | The Value of Authenticity & Intellectual Curiosity
|
Dec 20, 2023 |
|
🧬 Kittu Kolluri - Neotribe Ventures - Part 1 | Entrepreneurship as a First-Generation Immigrant | Working & Growing at Silicon Graphics | Learning From Mistakes & Pride of Ownership | The Dangers of Company Microcultures
|
Dec 13, 2023 |
|
🧬 Fengru Lin - TurtleTree - Part 3 | The Value of Early HR for Company Building | Creating a People-First Work Culture | Refocusing to Reach Commercialization Sooner | Navigating Seed Series Fundraising
|
Dec 06, 2023 |
|
🧬 Fengru Lin - TurtleTree - Part 2 | Salesforce’s Customer-Centric Sales Motion | The Value of Knowing Your Audience in Every Conversation | Why Executive Buy-In Matters | How a Hobby Led to TurtleTree’s Founding Idea
|
Nov 29, 2023 |
|
🧬 Fengru Lin - TurtleTree - Part 1 | Growing Up in Hong Kong & Singapore | Serendipity & Its Effect on Career Paths | Connecting the Dots in Business | The Complex & Fragile World of Food Production | The Importance of QA/QC
|
Nov 22, 2023 |
|
🧬 Sandy Paige - Seabright Ventures Fund - Part 4 | Creating Competitive Moats | Leveraging Financing Opportunities for Growth | The Purpose of a Board of Directors | Ambiguity as an Asset & Avoiding the Bias Toward Action
|
Nov 15, 2023 |
|
🧬 Sandy Paige - Seabright Ventures Fund - Part 3 | Managing International Distribution | Meaningful Work & Personal Buy-In as a Form of Equity | Getting Into Business Development & The Importance of Sales Experience | Starting & Running a Search Fund
|
Nov 08, 2023 |
|
🧬 Sandy Paige - Seabright Ventures Fund - Part 2 | Practicing Corporate Entrepreneurship | Life Lessons on How to Treat People | Seeking Margins & Avoiding Commodity | Scaling a Non-Profit | A CEO’s 3-5 Important Yearly Decisions
|
Nov 01, 2023 |
|
🧬 Sandy Paige - Seabright Ventures Fund - Part 1 | The Value of Hustle & Being a Team Player | Saying Yes to Opportunities | Corporate Entrepreneurship & Finding Your Path | Entrepreneurs & Risk Aversion
|
Oct 25, 2023 |
|
🧬 Maneesh Jain - Mirvie - Part 3 | Finding & Addressing Unmet Needs | The Maternal Health Crisis | Creating an Empathy-Focused Company Culture | Fundraising & Hitting Milestones in a Recession
|
Oct 18, 2023 |
|
🧬 Maneesh Jain - Mirvie - Part 2 | Company Size & Innovation | Supply Chain Learnings from Other Industries | Scaling Go-to-Market Strategies | Culture’s Interaction with Mergers & Acquisitions
|
Oct 11, 2023 |
|
🧬 Maneesh Jain - Mirvie - Part 1 | Fundamental Curiosity & The Value of Perseverance | Entrepreneurship for Societal Impact | “Magic Decades” & Finding Your Niche | The Importance of Scalability & Differentiation
|
Oct 04, 2023 |
|
🧬 Alok Tayi - Vibe Bio - Part 3 | Biotech2050 Podcast Origins | Facilitating Innovation Conversations in Biotech | Vibe Bio’s Mission & Funding Cures Instead of Finding Them | Non-Linear Growth & Thinking Long Term
|
Sep 20, 2023 |
|
🧬 Alok Tayi - Vibe Bio - Part 2 | Transitioning Into Entrepreneurship | The Importance of Sales Experience for Founders | The Power of a .edu Email | Managing Personnel During Hyperscaling
|
Sep 06, 2023 |
|
🧬 Alok Tayi - Vibe Bio - Part 1 | Combining Software & Science | The Influence of Serendipity on Trajectory | The Critical Importance of Mentors | Working to Make an Impact & Solve Problems
|
Aug 23, 2023 |
|
🧬 James Evans - PhenoVista - Part 3 | Being a Scrappy Founder | Adapting to Change & Learning to Pivot | The Importance of Professional Business Development | Setting Client Expectations
|
Aug 09, 2023 |
|
🧬 James Evans - PhenoVista - Part 2 | Leaving Academia for Industry | How to Handle Miscommunication | Creating a Truly Diverse Company Culture | Being Bootstrapped & Forging a Business Model in the Real World
|
Jul 26, 2023 |
|
🧬 James Evans - PhenoVista - Part 1 | Skateboarding, Resilience, & Problem Solving | The Importance of Hands-On Lab Experiences | The Elegant Simplicity of Trial & Error | Running the Whitehead Institute’s Core Facility
|
Jul 12, 2023 |
|
🧬 Steve Visco - PolyPlus - Part 3 | Government Grants | The Importance of Storytelling for STEM Startups | Venture Capital vs Non-Dilutive Funding | How To Gain Strategic Corporate Interest Domestically & Abroad
|
Jun 28, 2023 |
|
🧬 Steve Visco - PolyPlus - Part 2 | Global Competition | Defending & Monetizing Your Intellectual Property | Dealing With Patent Trolls & Needing Multiple Patents Per Technology | The Importance of Global IP Strategy for Startups
|
Jun 14, 2023 |
|
🧬 Steve Visco - PolyPlus - Part 1 | Benefits of Strong Writing Skills for Entrepreneurs | Tech Transfer Process & Its Origins | Leveraging Your Expert Status in Negotiations to Gain Investment | Evaluating Personal Needs Alongside Professional Opportuniti
|
May 31, 2023 |
|
🧬 Jacob Glanville - Centivax - Part 4 | How to Choose the Right Venture Capital Partner | Fundraising as “Dating” | Finding Proper Alignment & The Win-Win | VC Network as a “Polishing Engine”
|
May 17, 2023 |
|
🧬 Jacob Glanville - Centivax - Part 3 | Building a Biotech without Venture Capital | Picking Lab Space & Company Growth | Equipment Leasing & Runway/Cash Flow Maximization | Process Drift & “The Respiration Model”
|
May 03, 2023 |
|
🧬 Jacob Glanville - Centivax - Part 2 | Creating Bioinformatic Tools | Innovation vs. Organization in Biotech Companies | Finding Excitement in Your Work | Tech Transfer & “Separation of Church and State”
|
Apr 18, 2023 |
|
🧬 Jacob Glanville - Centivax - Part 1 | Hospitality Industry’s Applied Lessons | The Benefits of Contingency Planning & Fair Negotiation | How to Seek Translational Skill Sets & Cross Training
|
Mar 31, 2023 |
|
🧬 The Biotech Startups Podcast Trailer
|
Dec 07, 2022 |